Physician profile
Hong Chen
NPI 1194268540
$2,523.90
in general payments reported to CMS, 2019-2025
20 companies · $727 in 2025
The $727 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $246 · 2022: $252 · 2023: $331 · 2024: $967 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,025.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $884.49 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $306.15 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $247.38 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $223.95 | 2021-2024 | Mounjaro |
| Teva Pharmaceuticals USA, INC. | $179.58 | 2021 | |
| Agepha Pharma Fz LLC | $153.81 | 2025 | Lodoco |
| Bayer Healthcare Pharmaceuticals INC. | $93.91 | 2021-2025 | |
| Exact Sciences Corporation | $80.02 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $68.77 | 2024 | Veozah |
| Pfizer INC. | $48.22 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $42.35 | 2025 | Zoryve |
| Axsome Therapeutics, INC. | $38.04 | 2024 | Auvelity |
| Bioventus LLC | $25.91 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $25.72 | 2024 | Rexulti |
| Ardelyx, INC. | $21.58 | 2025 | Ibsrela |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $21.37 | 2022 | |
| Gilead Sciences, INC. | $18.52 | 2025 | |
| Corium, LLC | $16.28 | 2023 | Adlarity |
| Inspire Medical Systems, INC. | $14.95 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hong Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.